Ceftazidime is a third-generation cephalosporin antibiotic used as an active pharmaceutical ingredient. It functions by inhibiting peptidoglycan glycosyltransferase, an enzyme involved in bacterial cell wall synthesis.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 72558-82-8
Ceftazidime dihydrochloride
pharmaceutical raw material
Ceftazidime pentahydrate
pharmaceutical raw material
Cefpiramide
pharmaceutical raw material
Gadoteric acid
pharmaceutical raw material
Miglustat
pharmaceutical raw material
Dantrolene
pharmaceutical raw material
(−)-cathinone hydrochloride
pharmaceutical raw material
(6R,7R)-7-[[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-(2-carboxypropan-2-yloxyimino)acetyl]amino]-8-oxo-3-(pyridin-1-ium-1-ylmethyl)-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
ORFOPKXBNMVMKC-DWVKKRMSSA-N
CC(C)(C(=O)O)O/N=C(/C1=CSC(=N1)N)\C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C[N+]4=CC=CC=C4)C(=O)[O-]